Dark

BSX
Boston Scientific Corp.
stock NYSE

At Close

Jul 3, 2025 3:59:30 PM EDT

104.25USD+0.598%(+0.62)2,931,139

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 3, 2025 8:59:30 AM EDT

103.91USD+0.270%(+0.28)156

After-hours

Jul 2, 2025 4:33:30 PM EDT

103.63USD-0.010%(-0.01)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 28, 2022

08:08AM EST What Does Boston Scientific's Debt Look Like? Benzinga

Jan 25, 2022

12:14PM EST Boston Scientific Option Alert: Feb 18 $47 Calls Sweep (3) near the midpoint: 6240 @ $0.284 vs 997 OI; Earnings 2/2 Before Open Ref=$42.04 Benzinga

Jan 7, 2022

01:02PM EST Boston Scientific Highlights Will Present New Data On Advances In Chronic Pain Care AT 2022 North American Neuromodulation Society Meeting Jan. 14-15, 2022 Benzinga

07:00AM EST Boston Scientific to Present New Data on Advances in Chronic Pain Care at the PR Newswire

Jan 4, 2022

09:04AM EST Boston Scientific to Participate in J.P. Morgan Healthcare Conference and PR Newswire

Dec 21, 2021

07:19AM EST Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $53 Benzinga

Dec 15, 2021

10:02AM EST What Does Boston Scientific's Debt Look Like? Benzinga

Dec 10, 2021

12:41PM EST Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 Benzinga

05:00AM EST RBC Capital Initiates Coverage On Boston Scientific with Outperform Rating, Announces Price Target of $51 Benzinga

Dec 2, 2021

08:17AM EST Boston Scientific Corporation (BSX), a manufacturer of medical devices said on Thursday that has initiated the MODULAR ATP clinical trial to evaluate the safety, performance, and effectiveness of the mCRM Modular Therapy System. RTTNews

07:08AM EST Boston Scientific Initiates MODULAR ATP Trial To Evaluate MCRM Modular Therapy System RTTNews

07:07AM EST Boston Scientific Initiates Trial To Evaluate Industry's First Modular CRM System Benzinga

07:01AM EST Boston Scientific Initiates Trial to Evaluate Industry's First Modular CRM PR Newswire

Nov 8, 2021

09:33AM EST Boston Scientific To Participate In 2 Upcoming Investor Conferences: Nov. 15, 2021 At 8 a.m. EST For Stifel Healthcare Conference, Dec. 1, 2021 At 8 a.m. EST For Evercore ISI HealthCONx Conference Benzinga

09:31AM EST Boston Scientific Announces Upcoming Conference Schedule PR Newswire

Oct 28, 2021

07:29AM EDT Raymond James Maintains Strong Buy on Boston Scientific, Lowers Price Target to $51 Benzinga

Oct 27, 2021

09:17AM EDT Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations Benzinga

07:20AM EDT Recap: Boston Scientific Q3 Earnings Benzinga

06:51AM EDT While reporting financial results for the third quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its earnings, adjusted earnings and revenue growth guidance for the full-year 2021 and provided outlook for the fourth quarter. RTTNews

06:33AM EDT Boston Scientific Sees FY21 Adj. EPS $1.60-$1.62 vs $1.61 Est. Benzinga

06:32AM EDT Boston Scientific Q3 EPS $0.28 Vs Loss $0.12 Last Year RTTNews

06:32AM EDT Boston Scientific Q3 Adj. EPS $0.41 Beats $0.40 Estimate, Sales $2.93B Miss $2.97B Estimate Benzinga

06:31AM EDT Boston Scientific Announces Results For Third Quarter 2021 PR Newswire

03:43AM EDT Earnings Scheduled For October 27, 2021 Benzinga

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 6, 2021

03:38PM EDT Boston Scientific's Eluvia Drug-Eluting Vascular Stent Tops Bare Metal Stents Benzinga

12:36PM EDT Boston Scientific Says Eluvia Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal Stents Benzinga

12:36PM EDT Boston Scientific Eluvia(tm) Drug-Eluting Vascular Stent System Exhibits PR Newswire

08:37AM EDT Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis Deal Benzinga

07:17AM EDT Medical technology Company Boston Scientific Corp. (BSX) announced Wednesday that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. RTTNews

07:15AM EDT Boston Scientific Highlights Trial Data For EkoSonic System For Pulmonary Embolism Benzinga

07:02AM EDT Boston Scientific Announces Agreement To Acquire Baylis Medical Company Inc. For Upfront Payment Of $1.75B Benzinga

07:02AM EDT Boston Scientific Agrees To Acquire Baylis Medical Company For An Upfront Payment Of $1.75 Bln RTTNews

07:01AM EDT Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc. PR Newswire

Oct 5, 2021

04:23PM EDT Boston Scientific Highlights Late-Breaking Clinical Trial Data For Its EkoSonic Endovascular System Presented At Vascular InterVentional Advances Benzinga

04:22PM EDT Positive Late-breaking Clinical Trial Data for the EkoSonic(tm) Endovascular PR Newswire

12:36PM EDT Boston Scientific Reports Results For Ranger Drug-Coated Balloon During Late-Breaking Presentation At Vascular InterVentional Advances Meeting Benzinga

12:35PM EDT Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the PR Newswire

Oct 4, 2021

10:30AM EDT Boston Scientific Announces Conference Call Discussing Third Quarter 2021 PR Newswire

Sep 29, 2021

05:01PM EDT FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants Benzinga

Sep 22, 2021

12:50PM EDT UPDATE: Boston Scientific Sees FY21 Durable Organic Sales Growth 19-20%, Adj. EPS $1.58-$1.62 vs $1.61 Estimate Benzinga

12:49PM EDT UPDATE: Boston Scientific Investor Day Presentation Shows 6-8% Organic Sales Growth For FY22-FY24, Adj. EPS Growth In Double Digit Range Benzinga

Sep 21, 2021

08:42AM EDT Boston Scientific Acquires Provider Of Thrombectomy Platform In Over $300M Deal Benzinga

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

07:29AM EDT Boston Scientific Corporation (BSX) has reached an agreement to acquire Devoro Medical, Inc., developer of the WOLF Thrombectomy Platform. The transaction consists of an upfront payment of approximately $269 million for the 84 percent stake not yet owned and up to $67 million upon achievement of certain clinical and regulatory milestones. RTTNews

07:05AM EDT Boston Scientific Signs Deal To Buy Devoro Medical; Sees Deal To Close In Q4 RTTNews

07:02AM EDT Boston Scientific Announces Agreement to Acquire Devoro Medical For ~$269M Upfront And Up To $67 Upon Achievement Of Certain Clinical And Regulatory Milestones Benzinga

07:01AM EDT Boston Scientific Announces Agreement to Acquire Devoro Medical, Inc. PR Newswire

Sep 20, 2021

04:02PM EDT Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting Microbeads Benzinga

08:16AM EDT Boston Scientific Corp. (BSX) said that late-breaking data demonstrated improved progression-free survival in patients with metastatic colorectal cancer after treatment with boston scientific therasphere Y-90 Glass Microspheres. RTTNews

07:41AM EDT Boston Scientific Corporation Highlights Presentation Of EPOCH Clinical Trial Data At ESMO 2021 Benzinga

07:38AM EDT Boston Scientific Says EPOCH Clinical Trial Of TheraSphere Y-90 Glass Microspheres Meet Primary Endpoints RTTNews

07:36AM EDT with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere(tm) Y-90 Glass Microspheres PR Newswire

Sep 9, 2021

10:46AM EDT Boston Scientific Announces 2021 Investor Day Meeting PR Newswire

Sep 1, 2021

06:59AM EDT Boston Scientific Closes Acquisition Of Lumenis LTD. Surgical Business From Baring Private Equity Asia RTTNews

06:50AM EDT Boston Scientific Closes Acquisition Of Lumenis LTD. Surgical Business From PR Newswire

Aug 30, 2021

03:47PM EDT Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study Benzinga

Aug 21, 2021

12:04PM EDT Where Boston Scientific Stands With Analysts Benzinga

Aug 17, 2021

12:27PM EDT Post Market Studies Reinforce Unfavorable Risk-Benefit Profile For Boston Scientific's Vaginal Mesh Benzinga

Aug 11, 2021

07:38AM EDT Miromatrix Medical Reports Strategic Investors Were Involved In Series C Financing Following IPO: Baxter, CareDx, DaVita; No Size Of Investment Disclosed Benzinga

06:34AM EDT Boston Scientific's Exalt Model B Single-Use Bronchoscope Wins FDA Approval Benzinga

Aug 10, 2021

04:21PM EDT Boston Scientific Corp. (BSX) Tuesday said it received U.S. Food and Drug Administration clearance of the EXALT Model B Single-Use Bronchoscope, designed for use in bedside procedures within the intensive care unit and operating room. RTTNews

04:08PM EDT Boston Scientific Receives FDA Clearance For EXALT Model B Single-Use Bronchoscope RTTNews

04:00PM EDT Boston Scientific Receives FDA Clearance for EXALT(tm) Model B Single-Use PR Newswire

03:14PM EDT Boston Scientific Shares Quiet As FDA Says Co. Has Recalled Ingenio Family Of Pacemakers, CRT-PS, Cites Risk Of Transition To Safety Mode Benzinga

Aug 6, 2021

04:11PM EDT Boston Scientific Recalls Faulty Pacemakers Due To Risk of Incorrect Transition To Safety Mode Benzinga

11:50AM EDT UPDATE: FDA Says Has Identified Recall Of Ingenio Family Of Pacemakers And CRT-PS As Class I Recall Benzinga

11:48AM EDT FDA Says Boston Scientific Is Recalling Ingenio Family Of Pacemakers, CRT-PS Due To Risk Of Incorrect Transition To Safety Mode Benzinga

Aug 4, 2021

07:10AM EDT Boston Scientific Initiates Randomized Controlled Trial For EkoSonic Endovascular System RTTNews

07:04AM EDT Boston Scientific Initiates Randomized Controlled Trial For The EkoSonic Endovascular System Benzinga

07:02AM EDT Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic(tm) PR Newswire

Aug 3, 2021

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

Aug 2, 2021

04:57PM EDT Boston Scientific Reports US Centers for Medicare & Medicaid Services Granted Added Reimbursement For EXALT Model D Single-Use Duodenoscope Benzinga

04:56PM EDT CMS Grants Additional Reimbursement For EXALT(tm) Model D Single-Use PR Newswire

Jul 30, 2021

05:32PM EDT 'Fast Money Halftime Report' Picks For July 30 Benzinga

Jul 29, 2021

12:01PM EDT Expert Ratings For Boston Scientific Benzinga

Jul 28, 2021

09:02AM EDT Credit Suisse Maintains Outperform on Boston Scientific, Raises Price Target to $52 Benzinga

08:10AM EDT Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $53 Benzinga

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

07:20AM EDT Raymond James Maintains Strong Buy on Boston Scientific, Raises Price Target to $53 Benzinga

Jul 27, 2021

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

11:13AM EDT Boston Scientific Earnings Exceed Expectations As Demand Picks Up, Raises FY21 Guidance Benzinga

11:13AM EDT Recap: Boston Scientific Q2 Earnings Benzinga

06:34AM EDT Boston Scientific Sees FY21 Adj. EPS $1.58-$1.62 vs $1.58 Est., Sees Q3 Adj. EPS $0.39-$0.41 vs $0.40 Est. Benzinga

06:33AM EDT Boston Scientific Q2 Adj. EPS $0.40 Beats $0.37 Estimate, Sales $3.08B Beat $2.94B Estimate Benzinga

06:33AM EDT Boston Scientific Q2 GAAP EPS $0.12; Adj EPS $0.40 RTTNews

06:31AM EDT Boston Scientific Announces Results For Second Quarter 2021 PR Newswire

04:03AM EDT Earnings Scheduled For July 27, 2021 Benzinga

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 21, 2021

07:38AM EDT Boston Scientific (BSX) said that 24-month results from the PINNACLE FLX clinical trial demonstrated the safety and performance of WATCHMAN FLX left atrial appendage closure device for patients with non-valvular atrial fibrillation or NVAF. RTTNews

07:17AM EDT BSX: Trial Data At TVT Show Sustained Safety And Performance Of WATCHMAN FLX Left Atrial Appendage Closure Device RTTNews

07:15AM EDT Boston Scientific Announces Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX Left Atrial Appendage Closure Device Benzinga

07:14AM EDT Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of PR Newswire

Jul 7, 2021

09:59AM EDT UPDATE: Needham On Boston Scientific Corporation: Firm Sees Potential First Domestic Competitor If Abbott Laboratories's Amulet Is Approved By FDA During 2H21 Benzinga

09:59AM EDT Needham Maintains Hold Rating On Boston Scientific Corporation Benzinga

Jun 29, 2021

09:31AM EDT Boston Scientific Announces Conference Call Discussing Second Quarter 2021 PR Newswire

Jun 24, 2021

05:07PM EDT Boston Scientific Elects David Wichmann To Board Of Directors RTTNews

07:57AM EDT Medical technology firm Boston Scientific Corp. (BSX) announced Thursday it exercised its option to acquire the remaining 73 percent stake in Farapulse, Inc. for an upfront payment of approximately $295 million, up to $92 million upon achievement of certain clinical and regulatory milestones as well as additional revenue-based payments for the next three years. RTTNews

07:06AM EDT Boston Scientific's Debt Overview Benzinga

07:03AM EDT Boston Scientific Exercises Option To Acquire Remaining Shares Of Farapulse RTTNews

07:01AM EDT Boston Scientific Exercises Option To Acquire Farapulse, Inc.; Transaction Consists Of $295M Upfront Payment And Up To $92M Upon Certain Milestones Benzinga

07:01AM EDT Boston Scientific Exercises Option to Acquire Farapulse, Inc. PR Newswire

May 26, 2021

10:09AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2021 Benzinga

10:01AM EDT Boston Scientific shares were trading higher after Needham downgraded the stock from Buy to Hold. Benzinga

06:06AM EDT Needham Downgrades Boston Scientific to Hold Benzinga

May 25, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 Benzinga

07:02AM EDT Boston Scientific Completes CE Mark For The EXALT Model B Single-Use Bronchoscope RTTNews

06:55AM EDT Boston Scientific Completes CE Mark for EXALT(tm) Model B Single-Use PR Newswire

06:55AM EDT Boston Scientific Completes CE Mark For EXALT Model B Single-Use Bronchoscope Benzinga

06:44AM EDT Barclays Initiates Coverage On Boston Scientific with Overweight Rating, Announces Price Target of $51 Benzinga

May 24, 2021

09:31AM EDT Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions PR Newswire

May 21, 2021

02:38PM EDT Boston Scientific To Recall Its Vici Venous, Vici RDS Stent Systems For Potential Stent Migration Benzinga

May 18, 2021

03:01AM EDT Paravalvular Leak and Low Permanent Pacemaker Rates for the ACURATE neo2(tm) Aortic Valve System PR Newswire

May 14, 2021

10:50PM EDT BOSTON SCIENTIFIC INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX Business Wire

May 6, 2021

11:10AM EDT Raymond James Highlights Earlier ClinicalTrials.gov Record For Boston Scientific's Vortex Circulatory Support System; Notes Successful Commercialization Of Product Would Open Existing ~$900M Market; Sees Vortex As Competition For Abiomed's Impella Benzinga

07:01AM EDT OTC Markets Group Welcomes Belo Sun Mining Corp. to OTCQX PR Newswire

May 3, 2021

09:31AM EDT Boston Scientific Announces May Conference Schedule PR Newswire

Apr 30, 2021

10:50PM EDT Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX PR Newswire

01:03PM EDT Pete Najarian Sees Unusual Option Activity In Boston Scientific And Las Vegas Sands Benzinga

Apr 29, 2021

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

07:54AM EDT Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $51 Benzinga

Apr 28, 2021

02:23PM EDT Boston Scientific Stock Jumps On Q1 Earnings Beat, Improved Guidance Benzinga

07:26AM EDT The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping Benzinga

07:16AM EDT Boston Scientific: Q1 Earnings Insights Benzinga

06:59AM EDT Boston Scientific Sees Q2 Profit Above View; Lifts FY Outlook RTTNews

06:54AM EDT While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its earnings, adjusted earnings and revenue growth guidance for the full-year 2021 and provided the same outlook for the second quarter. RTTNews

06:36AM EDT Boston Scientific Corp (BSX) announced a profit for its first quarter that increased from the same period last year. RTTNews

06:33AM EDT Boston Scientific Q1 EPS $0.37 Beats $0.31 Estimate, Sales $2.75B Beat $2.62B Estimate Benzinga

06:31AM EDT Boston Scientific Q1 EPS $0.23 Vs $0.01 Last Year RTTNews

06:31AM EDT Boston Scientific Announces Results For First Quarter 2021 PR Newswire

04:15AM EDT Earnings Scheduled For April 28, 2021 Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 22, 2021

11:05AM EDT Cramer Gives His Opinion On Snap, Cleveland-Cliffs And More Benzinga

08:09AM EDT The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs Benzinga

Apr 16, 2021

Apr 15, 2021

10:47AM EDT Return On Capital Employed Overview: Boston Scientific Benzinga

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021 Benzinga

06:35AM EDT Atlantic Equities Initiates Coverage On Boston Scientific with Overweight Rating, Announces Price Target of $52 Benzinga

Mar 26, 2021

09:30AM EDT Boston Scientific Announces Conference Call Discussing First Quarter 2021 PR Newswire

Mar 25, 2021

12:37PM EDT Boston Scientific Corp. (BSX) Thursday announced positive data from study of the TheraSphere Y-90 Glass Microspheres, a type of radioembolization comprised of millions of microscopic glass beads containing radioactive yttrium. RTTNews

11:13AM EDT Boston Scientific :Trial Data For TheraSphere Y-90 Glass Microspheres Shows Improved Survival In Primary Liver Cancer RTTNews

11:09AM EDT Boston Scientific Shares Move Higher; Co Shares Late-Breaking Clinical Trial Data For TheraSphere Y-90 Glass Microspheres , Sayts Demonstrates Improved Survival In Primary Liver Cancer Benzinga

11:08AM EDT Late-Breaking Clinical Trial Data for TheraSphere(tm) Y-90 Glass Microspheres PR Newswire

Mar 23, 2021

12:15PM EDT Boston Scientific Shares Quiet; New York Attorney General Letitia James Says Secures Nearly $190M From Co, Says Coalition Of 48 Attorneys General Reach Deal With Co To Resolve Allegations Of Deceptive Marketing Of Transvaginal Surgical Mesh Products Benzinga

Mar 18, 2021

08:16AM EDT The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq Benzinga

07:03AM EDT Boston Scientific Gets FDA Approval For TheraSphere Y-90 Glass Microspheres RTTNews

07:02AM EDT Boston Scientific Receives FDA Approval For TheraSphere Y-90 Glass Microspheres Benzinga

07:01AM EDT Boston Scientific Receives FDA Approval for TheraSphere(tm) Y-90 Glass PR Newswire

Mar 3, 2021

07:46AM EST The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study Benzinga

07:15AM EST Medical devices company Boston Scientific Corp. (BSX) agreed Wednesday to acquire the global surgical business of Israel-based Lumenis LTD from an affiliate of Baring Private Equity Asia (BPEA) for an upfront cash payment of $1.07 billion, subject to closing adjustments. RTTNews

06:52AM EST Boston Scientific To Acquire Global Surgical Business Of Lumenis LTD. For Upfront Cash Payment Of $1.07 Bln RTTNews

06:51AM EST Boston Scientific Announces Agreement To Acquire Lumenis LTD For $1.07B In Cash Benzinga

06:50AM EST Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business PR Newswire

Feb 12, 2021

09:30AM EST Boston Scientific Announces February and March 2021 Conference Schedule PR Newswire

08:44AM EST 10 Biggest Price Target Changes For Friday Benzinga

05:51AM EST Needham Maintains Buy on Boston Scientific, Raises Price Target to $46 Benzinga

Feb 11, 2021

08:31AM EST Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 PR Newswire

Feb 10, 2021

07:00AM EST OTC Markets Group Welcomes Blackstone Minerals Ltd. to OTCQX PR Newswire

Feb 4, 2021

09:29AM EST Raymond James Maintains Strong Buy on Boston Scientific, Raises Price Target to $43 Benzinga

Feb 3, 2021

10:03AM EST Boston Scientific shares were trading lower after the company reported worse-than-expected Q4 EPS and sales results. The company also issued Q1 and FY21 EPS guidance below analyst estimates. Benzinga

07:31AM EST The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision Benzinga

07:23AM EST Recap: Boston Scientific Q4 Earnings Benzinga

06:48AM EST Boston Scientific Sees Q1, FY21 Profit Below View RTTNews

06:35AM EST Boston Scientific Corp (BSX) revealed earnings for fourth quarter that decreased from last year. RTTNews

06:35AM EST Boston Scientific Sees Q1 Adj. EPS $0.28-$0.34 vs $0.35 Est., FY21 Adj. EPS $1.50-$1.60 vs $1.62 Est. Benzinga

06:33AM EST Boston Scientific Q4 Adj. EPS $0.23 Misses $0.31 Estimate, Sales $2.71B Miss $2.83B Estimate Benzinga

06:32AM EST Boston Scientific Q4 Reported GAAP EPS $0.10 Per Share And Adj EPS $0.23 RTTNews

06:31AM EST Boston Scientific Announces Results For Fourth Quarter And Full Year 2020 PR Newswire

06:00AM EST Boston Scientific Corp. (BSX) will host a conference call at 8:00 AM ET on February 3, 2021, to discuss Q4 20 earnings results. RTTNews

04:00AM EST Earnings Scheduled For February 3, 2021 Benzinga

Feb 2, 2021

04:46PM EST Boston Scientific Recalls Emblem S-ICD Subcutaneous Electrode (Model 3501) Due To Risk Of Fractures Benzinga

01:50AM EST Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Boston Scientific Corporation - BSX PR Newswire

Feb 1, 2021

11:49AM EST Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire

11:00AM EST BSX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds GlobeNewswire Inc

09:43AM EST Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Boston Scientific Corporation PR Newswire

09:41AM EST BSX FINAL DEADLINE TOMORROW: ROSEN, TOP RANKED INVESTOR COUNSEL, GlobeNewswire Inc

Jan 31, 2021

05:33AM EST Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadline - BSX PR Newswire

Jan 30, 2021

11:21PM EST BSX FILING DEADLINE IN 4 DAYS: Bernstein Liebhard LLP Reminds GlobeNewswire Inc

01:19PM EST The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More Benzinga

Jan 29, 2021

10:50PM EST BOSTON SCIENTIFIC 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Boston Scientific Corporation - BSX Business Wire

Jan 28, 2021

12:00PM EST Glancy Prongay & Murray LLP (GPM) reminds investors of the upcomingFebruary 2, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Boston Scientific Corporation (Boston Scientific or the Company) (NYSE: BSX) securities between April 24, 2019 and November 16, 2020, inclusive (the Class Period). GlobeNewswire Inc

08:00AM EST Investors with losses are encouraged to contact the firm before February 3, 2021; click here to submit trade information GlobeNewswire Inc

Jan 27, 2021

07:18PM EST LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors with Losses PR Newswire

Jan 26, 2021

10:41PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

11:00AM EST DEADLINE ALERT for SPLK, BSX, QIWI and PEN: Law Offices of Howard GlobeNewswire Inc

11:00AM EST BSX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021 Business Wire

Jan 25, 2021

10:50PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

09:07PM EST Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who PR Newswire

12:07PM EST ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Boston Scientific GlobeNewswire Inc

11:30AM EST The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Jan 22, 2021

10:50PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

11:00AM EST Glancy Prongay & Murray LLP (GPM) reminds investors of the upcomingFebruary 2, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Boston Scientific Corporation (Boston Scientific or the Company) (NYSE: BSX) securities between April 24, 2019 and November 16, 2020, inclusive (the Class Period). GlobeNewswire Inc

07:13AM EST Boston Scientific Corp. (BSX) announced Friday that it has received U.S. Food and Drug Administration (FDA) approval of its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. RTTNews

07:06AM EST Boston Scientific Gets FDA Approval For Vercise Genus Deep Brain Stimulation System RTTNews

07:01AM EST Boston Scientific Receives FDA Approval For The Vercise Genus(tm) Deep Brain PR Newswire

07:00AM EST Boston Scientific Receives FDA Approval For The Vercise Genus Deep Brain Stimulation System Benzinga

Jan 21, 2021

06:53PM EST Investors of Important February 2 Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact Firm - BSX PR Newswire

11:00AM EST BSX, NERV & SMICY Class Actions: Bronstein, Gewirtz & Grossman LLC GlobeNewswire Inc

11:00AM EST The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

07:08AM EST Boston Scientific (BSX) said Thursday that it agreed to buy Preventice Solutions Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors to cardiac event monitors and mobile cardiac telemetry. RTTNews

06:57AM EST Boston Scientific Agrees To Acquire Preventice Solutions RTTNews

06:56AM EST Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc For $925M Upfront And Up To An Additional $300M In A Potential Commercial Milestone Payment Benzinga

06:55AM EST Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc. PR Newswire

Jan 20, 2021

07:22PM EST Portnoy Law: Lawsuit Filed On Behalf of Boston Scientific GlobeNewswire Inc

11:00AM EST The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class PR Newswire

11:00AM EST Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Jan 19, 2021

10:27PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

Jan 18, 2021

10:47PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

Jan 15, 2021

10:50PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

12:00PM EST Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class PR Newswire

Jan 14, 2021

07:14AM EST Boston Scientific (BSX) announced Thursday a limited market release of the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) systems. This is an unified portfolio of four MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators (IPGs). RTTNews

07:03AM EST Boston Scientific Launches WaveWriter Alpha Spinal Cord Stimulator Systems In US Benzinga

07:02AM EST Boston Scientific Unveils WaveWriter Alpha Spinal Cord Stimulator Systems In U.S. RTTNews

07:00AM EST Boston Scientific Launches WaveWriter Alpha(tm) Spinal Cord Stimulator Systems PR Newswire

Jan 13, 2021

10:27PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

05:30PM EST ROSEN, A TOP RANKED LAW FIRM, Reminds Boston Scientific GlobeNewswire Inc

11:01AM EST Deadline in the Class Action Lawsuit Against Boston Scientific Corporation (BSX) PR Newswire

Jan 12, 2021

10:50PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

12:24PM EST 33 Blue Chip Companies That Are Suspending Campaign Donations After Capitol Insurrection Benzinga

06:42AM EST Boston Scientific Corp. (BSX) reported net sales of approximately $2.71 billion during the fourth quarter of 2020, a decline of approximately 6.8 percent on a reported basis, approximately 8.3 percent on an operational basis and approximately 8.0 percent on an organic basis, year-on-year. RTTNews

06:32AM EST Boston Scientific Reports Q4 Preliminary Sales Of About $2.71 Bln, Down 6.8% On A Reported Basis RTTNews

06:31AM EST Boston Scientific Sees Prelim. Q4 Sales $2.71B vs $2.86B Est. Benzinga

06:31AM EST Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter PR Newswire

Jan 11, 2021

10:50PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

12:35PM EST Boston Scientific Corp Sees About $100M-$150M Of Charges Will Impact Adjusted Results; Says Recall Expected To Result In Estimated Total Pre-GAAP Charges Of About $225M-$300M Benzinga

12:34PM EST Boston Scientific Corp Says FDA Recall Decision Expected To Be Accretive For Co's GAAP, Adj. EPS In 2021 By About One To Two Cents, Neutral Thereafter Benzinga

12:30PM EST Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Jan 8, 2021

Jan 6, 2021

10:50PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

04:57PM EST Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who PR Newswire

03:32PM EST ROSEN, A TOP RANKED LAW FIRM, Reminds Boston Scientific GlobeNewswire Inc

09:24AM EST Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire

Jan 5, 2021

10:30PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

Jan 4, 2021

11:36AM EST Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

09:30AM EST Boston Scientific to Participate in J.P. Morgan Healthcare Conference and PR Newswire

Jan 3, 2021

03:12AM EST Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadline - BSX PR Newswire

Jan 1, 2021

10:50PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

Dec 31, 2020

12:54PM EST BSX SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors GlobeNewswire Inc

Dec 30, 2020

10:28PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

Dec 29, 2020

10:16PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

04:29PM EST Investors of the Important February 2 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - BSX PR Newswire

11:03AM EST Glancy Prongay & Murray LLP (GPM) reminds investors of the upcomingFebruary 2, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Boston Scientific Corporation (Boston Scientific or the Company) (NYSE: BSX) securities between April 24, 2019 and November 16, 2020 inclusive (the Class Period). GlobeNewswire Inc

11:00AM EST BSX, NERV & SMICY Class Actions: Bronstein, Gewirtz & Grossman LLC GlobeNewswire Inc

Dec 28, 2020

10:45PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

document.getElementById("GNV97j").onerror = function(){this.style.display='none';}; .dark-mode .Bc2TC3{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Bc2TC3{ color: #333333; background-color: white; border: 2px solid #333333; }BSXBoston Scientific Corp.stock NYSE

BSX
Boston Scientific Corp.
stock NYSE